Chipmaker Advanced Micro Devices Inc. (AMD) swung to a profit in the first quarter from a loss last year, as strong performance in its Computing and Graphics segment drove its revenue higher. The company also issued second-quarter revenue guidance that came above street expectations.
With revenues climbing 40% to $1.65 billion, the semiconductor company swung to quarterly earnings of $81 million or $0.08 per share, from a loss of $33 million or $0.04 per share a year earlier. On a non-GAAP basis, EPS were $0.11 compared to breakeven last year.
Revenue benefitted from strong sales of Radeon graphics, Ryzen processors and EPYC products.
Looking ahead into the second quarter of 2018, AMD predicts revenue of about $1.725 billion, plus or minus $50 million, an increase of 50% year-over-year, and non-GAAP gross margin of about 37%.
Off lately, demand for GPUs has been rising due to the wide use of artificial intelligence (AI) techniques and machine learnings tools in industries including gaming, automotive, and blockchain.
Client processor average selling price increased from last year, helped by a greater percentage of revenue from Ryzen products. Higher revenue from Radeon products drove average selling price of graphics processing unit. Enterprise, Embedded, and Semi-Custom (EESC) segment revenue fell 12% as lower semi-custom revenue overshadowed higher server and embedded revenue.
Cash rose 10.8% from last year as about 96% of it is held domestically. But on a sequential basis, cash for the period ended March 31, 2018, dropped 11.8% as the company lowered payables to related parties. It is expected that during next quarter, the company will have more cash due to the 63% increase in accounts receivable from December 30, 2017.
In contrast, the company needed quick financing to fund working capital needs as known from a 219% jump in short-term debt. The long-term debt had fallen drastically, while accumulated deficit narrowed slightly by 1.1%.
Shares of AMD ended Wednesday’s regular trading session down 3.77% at $9.71 on the Nasdaq Capital Market. The stock, which had been trading between $9.05 and $15.65 for the past 52 weeks, is now up 8.65% in the aftermarket hours.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on